CytoSorbents Corporation (CTSO)

[techxen]

Bridge Bank term debt still available

Also, don't forget the company restructured it's debt with Bridge Bank in March 2018. The Company replaced its existing $10 million term loan with $10 million of new debt.

Per Kathleen's comments:
"The new debt facility is structured as a four-year term loan with monthly payments of interest- only for the first 18 months, and this has reduced our cash needs over that same period by approximately $6 million. Another $5 million in term loan debt is available by March 2019 to further extend our operating runway should we choose to take it"

So from a cash perspective they should be fine with the Cantor ATM and debt facility, however I was really watching what was going to happen at the end of Q2. I was expecting another capital raise, especially after the dramatic stock price appreciation and knowing they still need to fund the US Hemodefend trial. That would have been an opportune time to raise money. My hopes are that they can get a partner for Hemodefend.